Distribution and Expression of Programmed Death Ligand -1 (PD-L1) in Non-Small Cell Carcinomas of the Lung in a Tertiary Care Centre in South India
Objective: Non-small cell lung carcinomas often present at an advanced stage with a grim prognosis. Immune checkpoint (ICP) inhibitors have drastically changed the scenario, and the response to ICP inhibitors is determined by analyzing the expression of PD-L1 by immunohistochemistry. PD-L1 immunohis...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2021-05-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkjpath.org/pdf.php3?id=1961
|